Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Mar 14, 2016 · 10-K · 74 days after period end · 0001140361-16-057543
| Metric | Q4 2015 | Q4 2014 | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 |
| Net Income | -$2.85M | -$2.21M | -$2.72M | -$55.40K |
| EPS Diluted | -$0.02 | -$0.01 | — | — |
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2015 · filed Mar 14, 2016 · 74 d after period end
